We are live on
!
Find out more
Wealth Enhancement Advisory Services Portfolio holdings
AUM
$59.8B
1-Year Est. Return
29.42%
This Fund
S&P 500
This Quarter
Est. Return
+8.76%
1 Year Est. Return
+29.42%
3 Year Est. Return
+77.06%
5 Year Est. Return
+66.38%
10 Year Est. Return
+178.95%
AUM
$60.5B
AUM Growth
+$8.17B
(+16%)
Cap. Flow
+$3.47B
Cap. Flow
% of AUM
5.74%
Top 10 Holdings %
Top 10 Hldgs %
23.65%
Holding
3,520
New
510
Increased
1,636
Reduced
1,103
Closed
162
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JMTG
JPMorgan Mortgage-Backed Securities ETF
JMTG
|
+$141M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$128M |
| 3 |
ALPS Smith Core Plus Bond ETF
SMTH
|
+$125M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$117M |
| 5 |
Apple
AAPL
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$131M |
| 2 |
JPMorgan Short Duration Core Plus ETF
JSCP
|
+$77.9M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$62.1M |
| 4 |
UnitedHealth
UNH
|
+$35.8M |
| 5 |
CBRE Group
CBRE
|
+$32.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.75% |
| 2 | Financials | 6.58% |
| 3 | Industrials | 4.51% |
| 4 | Consumer Discretionary | 3.84% |
| 5 | Healthcare | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Humacyte
HUMA
$194M
| $49.2K | ﹤0.01% |
+21,586
| New | +$41.5K |
|
|
HPP
3227
Hudson Pacific Properties
HPP
$779M
| $48.5K | ﹤0.01% |
+2,545
| New | +$41.3K |
|
3228
Pacific Biosciences
PACB
$370M
| $48.2K | ﹤0.01% |
30,113
+9,739
| +48% | +$11.2K |
|
|
SGMO
3229
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $47.7K | ﹤0.01% |
90,550
+21,300
| +31% | +$12.6K |
|
3230
Kosmos Energy
KOS
$1.48B
| $47.1K | ﹤0.01% |
+23,807
| New | +$43.1K |
|
3231
JetBlue
JBLU
$2.29B
| $47K | ﹤0.01% |
+10,545
| New | +$47.2K |
|
3232
GoPro
GPRO
$126M
| $46.6K | ﹤0.01% |
62,581
-13,579
| -18% | -$8.82K |
|
3233
NGL Energy Partners
NGL
$2.11B
| $46.5K | ﹤0.01% |
10,883
| – | – |
|
|
SVC
3234
Service Properties Trust
SVC
$1.07B
| $46.3K | ﹤0.01% |
3,558
-1,448
| -29% | -$15.6K |
|
3235
Hyperfine
HYPR
$101M
| $45.3K | ﹤0.01% |
56,625
+300
| +0.5% | +$210 |
|
3236
Century Therapeutics
IPSC
$361M
| $45.1K | ﹤0.01% |
81,247
-3,836
| -5% | -$2.06K |
|
3237
CPI Aerostructures
CVU
$68.5M
| $44.7K | ﹤0.01% |
13,350
+1,850
| +16% | +$5.97K |
|
3238
Chegg
CHGG
$102M
| $44.4K | ﹤0.01% |
30,861
+15,549
| +102% | +$14.4K |
|
3239
Hyliion Holdings
HYLN
$690M
| $44.1K | ﹤0.01% |
+30,616
| New | +$44.6K |
|
3240
Larimar Therapeutics
LRMR
$432M
| $43.6K | ﹤0.01% |
+13,629
| New | +$31.6K |
|
3241
ImmunityBio
IBRX
$8.1B
| $43.3K | ﹤0.01% |
+15,933
| New | +$42.8K |
|
3242
Iovance Biotherapeutics
IOVA
$2.87B
| $43.3K | ﹤0.01% |
24,735
-2,716
| -10% | -$6.76K |
|
|
OGI
3243
Organigram Holdings
OGI
$139M
| $42K | ﹤0.01% |
29,387
-695
| -2% | -$846 |
|
|
CGC
3244
Canopy Growth
CGC
$410M
| $41.4K | ﹤0.01% |
32,336
+14,498
| +81% | +$19.3K |
|
3245
Oramed Pharmaceuticals
ORMP
$179M
| $41K | ﹤0.01% |
18,799
+5,000
| +36% | +$11K |
|
3246
Fate Therapeutics
FATE
$326M
| $39.6K | ﹤0.01% |
35,347
+5,438
| +18% | +$6.32K |
|
3247
iHeartMedia
IHRT
$583M
| $39.4K | ﹤0.01% |
20,187
-7,419
| -27% | -$9.88K |
|
3248
CALL
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$332M
| $39.4K | ﹤0.01% |
4,800
+1,510
| +46% | +$93.1K |
|
3249
Microvision
MVIS
$78.9M
| $38.1K | ﹤0.01% |
+2,227
| New | +$38.6K |
|
3250
Nkarta
NKTX
$172M
| $37.8K | ﹤0.01% |
21,620
+4,255
| +25% | +$7.8K |
|
Similar funds
QCM
NAMI
Wealth Enhancement Advisory Services's Q2 2025 Portfolio in Review
As of Q2 2025, Wealth Enhancement Advisory Services held 3,520 positions worth $60.5B, up 16% from $52.3B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Wealth Enhancement Advisory Services deployed $3.47B of net new capital in Q2 2025, opening 510 new positions and adding to 1,636 existing holdings. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 2,815,302 shares worth $141M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Palantir, an estimated $131M trimmed.
- Wealth Enhancement Advisory Services's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 2,815,302 shares worth $141M.
- Wealth Enhancement Advisory Services added most to iShares Core US Aggregate Bond ETF in Q2 2025, an estimated $128M increase.
- Wealth Enhancement Advisory Services's biggest Q2 2025 reduction was Palantir, cutting an estimated $131M.
- Wealth Enhancement Advisory Services fully exited Discover Financial Services in Q2 2025, selling an estimated $10.8M.
- Wealth Enhancement Advisory Services's ten largest holdings make up 24% of its $60.5B portfolio in Q2 2025.
- Wealth Enhancement Advisory Services opened 510 new positions and closed 162 in Q2 2025.
- Wealth Enhancement Advisory Services's portfolio value rose 16% quarter-over-quarter to $60.5B.
Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2025, filed 10 Jul 2025.